Can-Fite BioPharma
AboutSciencePipelineInvestor InformationContact Us

About Can-Fite BioPharma

About Us

Company Leadership
- Management
- Drug Dev. Team
- Board of Directors


Board of Directors

Ilan Cohn, Ph.D., Chairman
Dr. Ilan Cohn is a co-founder of the company and it’s Chairman. Dr. Cohn is a senior partner of Reinhold Cohn & Partners the largest IP firm in Israel. He manages the life sciences and chemistry department of Reinhold Cohn, which includes a very large staff of patent attorneys, trainees, paralegals, and assistant staff. Dr. Cohn, has many years of experience in the field of patents and other intellectual property fields. Additionally, in the course of his professional career Ilan gained significant experience and expertise in turning intellectual property assets, particularly patents into a first tier asset. He holds a Ph.D. in biology. He served on the board of directors of a number of life science companies in Israel and in the USA. He was also involved in the past in management of VC funds focused on investment in the field of the life sciences. Dr. Cohn served a number of years as a co-chairman of the Biotech Committee of the US-Israeli Science and Technology Commission.
Prof. Pnina Fishman, Ph.D., CEO
Prof. Fishman is the scientific founder of the company and was previously a professor of Life Sciences and headed the Laboratory of Clinical and Tumor Immunology at the Felsenstein Medical Research Institute, Rabin Medical Center. Prof. Fishman is a very accomplished scientist and has authored or co-authored over 150 publications and presented the findings of her research at many major scientific meetings. Her scientific work was the foundation on which Can-Fite was built. This scientific work has gained recognition as one of the leading approaches for new generation therapies for cancer and other diseases. Her past managerial experience included seven years as CEO of Mor Research Application (MRA), a company that was in charge of the commercialization of intellectual property from all hospitals and research centers of Clalit Health Services, the largest healthcare provider in Israel, and was also the first clinical CRO in Israel. She was also involved in the establishment and served on the Board of Directors of several life sciences technology start-ups.
Liora Lev
Mrs. Lev is a partner in Ascend Technology Ventures, an investor in Can-Fite. She is an accomplished CPA with over 20 years of experience in business management, information systems management and finance of public and private companies. For a period of 5 years before founding Ascend, Liora served as Commissioner at the Israel Securities Authority (ISA) and as a member of ISA`s Stock Exchange Committee and the Israeli Accounting Standards Board. During this time she also held the position of CFO of Ashtrom, a leading Israeli holding group.
Avraham Sartani, MD.
Dr. Sartani was till recently a Vice-President and Director Pharmaceutical Research and Development Division, of Recordati. Prior to joining Recordati in 1985, Dr. Sartani was in Farmitalia-carlo Erba since 1980, serving in an number of roles including the Medical Director for Europe. He is a member of a number of scientific and management societies and the author/co-author of numerous publications and patents.
Yechezkel Barenholz, Ph.D.
Yechezkel (Chezy) Barenholz, PhD, is Professor of Biochemistry and the Daniel G. Miller Professor in Cancer Research. He is the head of the Laboratory of Membrane and Liposome Research at the Department of Biochemistry, the Hebrew University, Hadassah Medical School, Jerusalem, Israel. Prof.  Barenholz is one of the leading and most successful enterpeneurals in Israel. He has started couple of companies based on technologies developed in his academic lab and led the team that developed DOXIL.
Gil Oren
Gil Oren established his own consulting firm 5 years ago. Before that he held top managerial positions in various public companies in Israel and the US. After five years as CFO of Tadiran Electronic`s subsidiary in the US, Gil returned to Israel and joined Cargal, first as VP finance, and then as CEO and GM. In 2002 Gil moved to SFK, a leading Israeli investment group. He was the CEO of Itong Industries and Orlite Industries, and served as a member of the BOD of those companies, as well as others ( including Nirlat, Aloni etc.). 
Guy Regev
Mr. Guy Regev is currently the Chief Executive Officer of Shaked Global Group, a privately-held equity investment firm that provides value added capital to environmental related companies and technologies. Shaked Global Group is a major shareholder in Can-Fite BioPharma and Mr. Regev is a director of Can-Fite. Mr. Regev has over 12 years of experience in accounting, financial management and control and general management of commercial enterprises. Prior to joining Shaked, Mr. Regev was Vice President, commercial business, at Housing & Construction Holding (“HCH”), Israel’s largest infrastructure company. Between 1999 and 2001, Mr. Regev was a manager at Deloitte & Touche, Israel.